Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Daiichi Sankyo
AstraZeneca
Medtronic
Farmers Insurance
Federal Trade Commission
Queensland Health
Colorcon
Deloitte

Generated: January 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,698,559

« Back to Dashboard

Summary for Patent: 5,698,559
Patent Claims: 1. A compound of the formula ##STR58## where Q is selected from the group consisting of ##STR59## R.sup.1 is selected from the group consisting of 4-, 3-, or 2-pyridyl, pyrimidyl, pyrazinyl, and fluoro-4-pyridyl;

R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, --NO.sub.2, --OH, R.sup.4, --OR.sup.4, --CO.sub.2 R.sup.4, --COR.sup.4, --CONH.sub.2, --CONHR.sup.4, --CONR.sup.4 R.sup.4', --S(O).sub.m --R.sup.4, --NH.sub.2, --CF.sub.3, --NHR.sup.4, and --NR.sup.4 R.sup.4' ;

R.sup.4 and R.sup.4' are independently selected from the group consisting of H, alkyl of 1 to 4 carbons, --CH.sub.2 Phe-W and --Phe-W;

Phe is a phenyl group;

R.sup.5 is selected from the group consisting of --(CH.sub.2).sub.n --Y and --OCOR.sup.4 ;

Y is selected from the group consisting of H, --OH, --NH.sub.2, --NHR.sup.4, --NR.sup.4 R.sup.4', --NHCO.sub.2 R.sup.4, --NHS(O).sub.2 R.sup.4, F, Cl, Br, --OR.sup.4, --S(O).sub.m R.sup.4, --CO.sub.2 H, --CO.sub.2 R.sup.4, --CN, --CONR.sup.4 R.sup.4' --CONHR.sup.4, --CONH.sub.2, --COR.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, --OCOR.sup.4, -Phe, -Phe-W, --C.tbd.CCO.sub.2 R.sup.4, --CH.dbd.CHR.sub.4, and --C.tbd.C R.sup.4 ;

W is selected from the group consisting of F, Cl, Br, --NO.sub.2, --NH.sub.2, and --CN;

m is 0, 1 or 2;

n is 1 to 7;

and hydrates and physiologically suitable salts thereof.

2. A compound of claim 1 where R.sup.1 is selected from the group consisting of 4-pyridyl, 4-pyrimidyl, and 2-fluoro-4-pyridyl.

3. A compound of claim 1 where R.sub.5 is --(CH.sub.2).sub.n --Y.

4. A compound of claim 3 where Y is selected from the group consisting of --CO.sub.2 R.sup.4, --CN, --CONHR.sup.4, --NHCOR.sup.4, --NHCO.sub.2 R.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, and --OCOR.sup.4.

5. A compound of claim 1 where R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, OH, --R.sup.4, --OR.sup.4, --CO.sub.2 R.sup.4, --COR.sup.4, --CONH.sub.2, --CONHR.sup.4, --CONR.sup.4 R.sup.4' and --S(O)m.sup.R.sup.4, and R.sup.4 and R.sup.4' are independently selected from the group consisting of alkyl of 1 to 4 carbon atoms.

6. A compound of claim 2 where R.sub.5 is --(CH.sub.2).sub.n --Y and n is 1 to 4.

7. A compound of claim 6 where Y is selected from the group consisting of --CO.sub.2 R.sup.4, --CN, --CONHR.sup.4, --NHCOR.sup.4, --NHCO.sub.2 R.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, and --OCOR.sup.4.

8. A compound of claim 6 where R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, --CH.sub.3 and --CO.sub.2 R.sup.4, and R.sup.4 is selected from the group consisting of alkyl of 1 to 4 carbons.

9. The compound of claim 1 which is 4-[9-(4-Pyridinylmethyl)-9H-fluoren-9-yl]-2-butenoic Acid Ethyl Ester Dihydrochloride.

10. The compound of claim 1 which is 9-(4-Pyridinylmethyl)-9H-fluoren-9-acetic Acid Ethyl Ester Hydrochloride.

11. The compound of claim 1 which is 9-(4-Pyridinylmethyl)-9H-fluoren-9-butanamide Hemihydrate.

12. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 1.

13. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 2.

14. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 3.

15. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 4.

16. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 5.

17. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 6.

18. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 7.

19. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 8.

20. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 9.

21. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 10.

22. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 11.

23. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 1.

24. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 2.

25. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 3.

26. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 4.

27. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 5.

28. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 6.

29. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 7.

30. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 8.

31. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 9.

32. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 10.

33. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 11.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
US Department of Justice
Merck
Farmers Insurance
UBS
Colorcon
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot